Walmart is set to replace AstraZeneca in the Nasdaq-100 index on January 20, moving its shares from the NYSE to Nasdaq.
What’s Changing?
Starting before the market opens on Jan 20, Walmart will be added to the Nasdaq-100, the Nasdaq-100 Equal Weighted Index, and the Nasdaq-100 Ex‑Tech Sector Index. In return, AstraZeneca will be removed.
Why Walmart Is Moving
Companies often switch exchanges to reach a larger pool of investors, benefit from better technology, or lower listing costs. The Nasdaq-100 is popular because it gathers the 100 biggest non‑financial firms on Nasdaq, such as Apple and Nvidia, which can attract more interest.
Potential Impact on Investors
- Retail investors: May see more trading activity and liquidity for Walmart shares.
- Index funds: Funds that track the Nasdaq-100 will need to adjust their holdings, which could cause short‑term price movements.
- AstraZeneca shareholders: The drugmaker will no longer be part of the Nasdaq-100, possibly reducing its visibility among tech‑focused investors.
Overall, the change highlights Walmart’s aim to align with a broader investor base and the growing appeal of the Nasdaq-100 for large, non‑financial companies.
Remember, this is perspective, not a prediction. Do your own research before making any investment decisions.